Randomized clinical trials of neurally mediated syncope

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 9 SUPPL., 2003, Pages

  Brignole, Michele ^a  

^a DEPARTMENT OF CARDIOLOGY   (Italy)

Author keywords

Drug therapy cardiac pacing; Neurally mediated syncope

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DIHYDROERGOTAMINE; DISOPYRAMIDE; ENALAPRIL; EPHEDRINE; ETILEFRINE; FLUDROCORTISONE; METOPROLOL; MIDODRINE; PAROXETINE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE;

ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CAROTID SINUS SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; HEART PACING; HUMAN; INOTROPISM; LONG TERM CARE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SIDE EFFECT; SYNCOPE; TILT TABLE TEST; TREATMENT OUTCOME;

EID: 0141501325     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.14.s9.7.x     Document Type: Conference Paper

References (51)

1. Tonnesen G, Haft J, Fulton J, Rubenstein D: The value of tilt testing with isoproterenol in determining therapy in adults with syncope and presyncope of unexplained origin. Arch Intern Med 1994;154:1613-1617.
2. Jhamb DK, Singh B, Sharda B, Kaul U, Goel P, Talwar KK, Wasir HS: Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response. Am Heart J 1996;132:608-611.
3. Biffi M, Boriani G, Sabbatani P, Bronzetti G, Frabetti L, Zannoli R, Branzi A, Magnani B: Malignant vasovagal syncope: A randomised trial of metoprolol and clonidine. Heart 1997;77:268-272.
4. Cohen MB, Snow JS, Grasso V, Lehnert L, Goldner BG, Jadonath RL, Cohen TJ: Efficacy of pindolol for treatment of vasovagal syncope. Am Heart J 1995;130:786-790.
5. Iskos D, Dutton J, Scheinman MM, Lurie KG: Usefulness of pindolol in neurocardiogenic syncope. Am J Cardiol 1998;82:1121-1124.
6. Muller G, Deal B, Strasburger JF, Benson DW Jr: Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol 1993;71:592-595.
7. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S: Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995;130:1250-1253.
8. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D: A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992;70:339-342.
9. Sheldon R, Rose S, Flanagan P, Koshman L, Killam S: Effects of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996;78:536-539.
10. Di Gerolamo E, Di Iorio C, Sabatini P, Leonzio L, Barsotti A: Effects of different treatments vs no treatment on neurocardiogenic syncope. Cardiologia 1998;43:833-837.
11. Madrid A, Ortega I, Rebollo GJ, Manzano JG, Segovia JG, Sanchez A, Pena G, Moro C: Lack of efficacy of atenolol for the prevention of neurally-mediated syncope in highly symptomatic population: A prospective double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001;37:554-557.
12. Ventura R, Maas R, Zeidler D, Schoder V, Nienaber CA, Schuchert A, Meinertz T: A randomized and controlled pilot trial of β-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 2002;25:816-821.
13. Flevari P, Livanis E, Theodorakis G, Zarvalis E, Mesiskli T, Kremastinos DT: Vasovagal syncope: A prospective, randomized, cross-over evaluation of the effects of propranolol, nadolol and placebo on syncope recurrence and patients' well-being. J Am Coll Cardiol 2002;40:499-504.
14. Fitzpatrick AP, Ahmed R, Williams S, Sutton R: A randomized trial of medical therapy in malignant vasovagal syndrome or neurally-mediated bradycardia/hypotension syndrome. Eur J Card Pacing Electrophysiol 1991;1:191-202.
15. Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A: Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: A double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 1999;99:1452-1457.
16. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, Carne X, Rius T, Mont L, Soler-Soler J: Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: Results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995;25:65-69.
17. Ward CR, Gray JC, Gilroy JJ, Kenny RA: Midodrine: A role in the management of neurocardiogenic syncope. Heart 1998;79:45-49.
18. Perez-Lugones A, Schweikert R, Pavia S, Sra J, Akhtar M, Jaeger F, Tomassoni GF, Saliba W, Leonelli FM, Bash D, Beheiry S, Shewchik J, Tchou PJ, Natale A: Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: A randomized control study. J Cardiovasc Electrophysiol 2001;12:935-938.
19. Jankovic J, Gilden JL, Hiner BC, Brown DC, Rubin M: Neurogenic orthostatic hypotension: A double-blind placebo-controlled study with midodrine. Am J Med 1993;95:38-48.
20. Gilden JL: Midodrine in neurogenic orthostatic hypotension. Int Angiol 1993;12:125-131.
21. Low PA, Gilden JL, Freeman R, Sheng K-N, McElligott MA: Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. JAMA 1997;13:1046-1051.
22. Kaufmann H, Saadia D, Voustianiouk A: Midodrine in neurally-mediated syncope: A double-blind, randomized, cross-over study. Ann Neurol 2002;52:342-245.
23. Di Gerolamo E, Di lorio C, Sabatini O, Leonzio L, Barbone C, Barsotti A: Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999;33:1227-1230.
24. Takata T, Wasmund S, Smith M, Li JM, Joglar JA, Banks K, Kowal RC, Page RL, Hamdan MH: Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Pacing Clin Electrophysiol 2002;106:1500-1504.
25. Lee TM, Su SF, Chen MF, Liau CS: Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 1996;78:480-482.
26. Morillo CA, Leitch JW, Yee R, Klein GL: A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-1848.
27. Zeng C, Zhu Z, Liu G, Hu W: Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope. Am Heart J 1998;136:852-858.
28. Sra J, Anderson A, Sheikh S, Avitall B, Tchou PJ, Troup PJ, Gilbert CJ, Akhtar M, Jazayeri MR: Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med 1991;114:1013-1019.
29. Connolly SJ, Sheldon R, Roberts RS, Gent M, Vasovagal Pacemaker Study Investigators: The North American Vasovagal Pacemaker Study (VPS): A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20.
30. Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P, Moya A: Dual-chamber pacing in treatment of neurally-mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multicentre randomized study. Circulation 2000;102:294-299.
31. Ammirati F, Colivicchi F, Santini M: Permanent Cardiac Pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Circulation 2001;104:52-57.
32. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M, for the VPS II Investigators: Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II). JAMA 2003;289:2224-2229.
33. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Mont L, Alvarez M, Errazquin F, Beiras J, Bottoni N, Donateo P: Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001;104:1261-1267.
34. Steering Committee of the ISSUE 2 study: International Study on Syncope of Uncertain Etiology 2 (ISSUE 2): The management of patients with suspected or certain neurally-mediated syncope after the initial evaluation. Rationale and study design. Europace 2003;(in press).
35. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, Fitzpatrick A, Hohnloser S, Kapoor W, Kenny RA, Theodorakis G, Kulakowski P, Moya A, Raviele A, Sutton R, Wieling W, Janousek J, van Dijk G: Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001;22:1256-1306.
36. Kenny RA, Richardson DA, Steen N, Bexton RS, Shaw FE, Bond J: Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol 2001;38:1491-1496.
37. Brignole M, Menozzi C, Lolli G, Bottoni N, Gaggioli G: Long-term outcome of paced and non paced patients with severe carotid sinus syndrome. Am J Cardiol 1992;69:1039-1043.
38. Voss DM, Magnin GE: Demand pacing and carotid sinus syncope. Am Heart J 1970;79:544-547.
39. Peretz DP, Gerein AN, Miyagishima RT: Permanent demand pacing for hypersensitive carotid sinus syndrome. Can Med Assoc J 1973;108:1131-1134.
40. Morley CA, Perrins EJ, Grant PL, Chan SL, McBrien DJ, Sutton R: Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrioventricular sequential pacing. Br Heart J 1982;47:411-418.
41. Brignole M, Menozzi C, Lolli G, Oddone D, Gianfranchi L, Bertulla A: Validation of a method for choice of pacing mode in carotid sinus syndrome with or without sinus bradycardia. Pacing Clin Electrophysiol 1991;14:196-203.
42. Sugrue DD, Gersh BJ, Holmes DR, Wood DL, Osborn MJ, Hammill SC: Symptomatic "isolated" carotid sinus hypersensitivity: Natural history and results of treatment with anticholinergic drugs or pacemaker. J Am Coll Cardiol 1986;7:158-162.
43. Madigan NP, Flaker GC, Curtis JJ, Reid J, Mueller KJ, Murphy TJ: Carotid sinus hypersensitivity: Beneficial effects of dual-chamber pacing. Am J Cardiol 1984;53:1034-1040.
44. Deschamps D, Richard A, Citron B, Chaperon A, Binon JP, Ponsonaille J: Hypersensibilite sino-carotidienne. Evolution a moyen et a long terme des patients traites par stimulation ventriculaire. Arch Mal Coeur 1990;83:63-67.
45. Blanc JJ, Boschat J, Penther P: Hypersensibilité sino-carotidienne. Evolution à moyen terme en fonction du traitement et de ses symptômes. Arch Mal Coeur 1984;77:330-336.
46. Menozzi C, Brignole M, Lolli G, Bottoni N, Oddone D, Gianfranchi L, Gaggioli G: Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol 1993;72:1152-1155.
47. Ector H, Reybrouck T, Heidbuchel H, Gewillig M, Van de Wed F: Tilt training: A new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol 1998;21:193-196.
48. Di Girolamo E, Di Iorio C, Leonzio L, Sabatini P, Barsotti A: Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents. A controlled study. Circulation 1999;100:1798-1801.
49. Abe H, Kondo S, Kohshi K, Nakashima Y: Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope. Pacing Clin Electrophysiol 2002;25:1454-1458.
50. Brignole M, Croci F, Menozzi C, Solano A, Donateo P, Oddone D, Puggioni E, Lolli G: Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002;40:2054-2060.
51. Krediet P, van Dijk N, Linzer M, Lieshout J, Wieling W: Management of vasovagal syncope: Controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002;106:1684-1689.